Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.

by Kate Yandell

Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.

by Kevin McLaughlin

Researchers are investigating why certain patients have an exceptional response to a particular drug.

by Bradley Jones

NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”

by Kevin McLaughlin

Geriatric assessment reduces toxicity from treatment and improves quality of life in older adults with cancer.

by Marci A. Landsmann

Data shed light on risk factors for death among people with cancer infected with the coronavirus.

by Kate Yandell

Researchers from around the globe share insights into the outcomes of people with cancer who are infected with the coronavirus.

by Bradley Jones

At the AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis.

by Kate Yandell

Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.

by Marci A. Landsmann

Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.

by Marci A. Landsmann